ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,942.47
1.26%
US Tech 100
20,762.73
1.73%
Dow Jones
42,732.13
0.80%
Brent Oil
76.495
0.00%
Bitcoin
98,112.02
-0.10%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Europe
  5. EU

  6. Galapagos (GLPG) Quote

Galapagos

Galapagos (GLPG)

Galapagos NV
27.38
-0.08
(-0.29%)
Closed January 04 11:30AM
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
27.38
Bid
27.10
Ask
27.48
Volume
51,147
27.06 Day's Range 27.50
22.00 52 Week Range 39.00
Market Cap
1.804B
Previous Close
27.46
Open
27.40
Last Trade
11
@
27.38
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
88,483
Shares Outstanding
65,897,000
Dividend Yield
-
PE Ratio
8.52
Earnings Per Share (EPS)
3.21
Revenue
843.8M
Net Profit
211.7M

About Galapagos

Sector
Coml Physical, Biologcl Resh
Industry
Coml Physical, Biologcl Resh
Website
www.glpg.com
Headquarters
Mechelen, Antwerp, Bel
Founded
-
Galapagos is listed in the Coml Physical, Biologcl Resh sector of the Euronext with ticker GLPG. The last closing price for Galapagos was 27.46 €. Over the last year, Galapagos shares have traded in a share price range of 22.00 € to 39.00 €.

Galapagos currently has 65,897,000 shares outstanding. The market capitalization of Galapagos is 1.81 € billion. Galapagos has a price to earnings ratio (PE ratio) of 8.52.

Ask ADVFN Intelligence (AI)

GLPG Latest News

More News

Galapagos Announces Encouraging New Results from Ongoing Phase 1/2 Study of CD19 CAR T-Cell Therapy, GLPG5101, in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma

Data from the ongoing Phase 1/2 ATALANTA-1 study in a heavily pretreated R/R NHL patient population demonstrate high antitumor activity and an encouraging safety profile in all NHL subtypes...

December 07 2024
GlobeNewswire Inc.

Galapagos Announces Encouraging New Results from Ongoing Phase 1/2 Study of CD19 CAR T-Cell Therapy, GLPG5101, in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma

Galapagos Announces Encouraging New Results from Ongoing Phase 1/2 Study of CD19 CAR T-Cell Therapy, GLPG5101, in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma Data from the ongoing Phase...

December 07 2024
UK Regulatory

Galapagos to Present Results of Pioneering Innovation in Cancer Cell Therapy at ASH 2024

Galapagos to Present Results of Pioneering Innovation in Cancer Cell Therapy at ASH 2024 New Phase 1/2 data support the potential of our CAR T-cell therapy candidates, GLPG5101 and GLPG5201, in...

November 05 2024
UK Regulatory

Galapagos to Present Results of Pioneering Innovation in Cancer Cell Therapy at ASH 2024

New Phase 1/2 data support the potential of our CAR T-cell therapy candidates, GLPG5101 and GLPG5201, in addressing unmet needs for patients with poor prognoses. Our innovative decentralized cell...

November 05 2024
GlobeNewswire Inc.

Galapagos Reports Third Quarter 2024 Financial Results and Provides Business Update

Galapagos Reports Third Quarter 2024 Financial Results and Provides Business Update We are advancing our pipeline and accelerating innovation through focused execution of our Forward, Faster...

October 30 2024
UK Regulatory

Galapagos Reports Third Quarter 2024 Financial Results and Provides Business Update

We are advancing our pipeline and accelerating innovation through focused execution of our Forward, Faster strategy.We are committed to addressing the high unmet needs of patients through a...

October 30 2024
GlobeNewswire Inc.

Galapagos welcomes Oleg Nodelman to its Board of Directors to support strategic growth

Mechelen, Belgium; October 7, 2024, 07:00 CET — Galapagos NV (Euronext & NASDAQ: GLPG), today announced the appointment by way of co-optation of Oleg Nodelman as Non-Executive Non-Independent...

October 07 2024
GlobeNewswire Inc.

Galapagos welcomes Oleg Nodelman to its Board of Directors to support strategic growth

Galapagos welcomes Oleg Nodelman to its Board of Directors to support strategic growth Mechelen, Belgium; October 7, 2024, 07:00 CET — Galapagos NV (Euronext & NASDAQ: GLPG), today announced...

October 07 2024
UK Regulatory

Galapagos receives transparency notification from EcoR1 Capital

Galapagos receives transparency notification from EcoR1 Capital Mechelen, Belgium; 30 September 2024, 22:01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) received a...

September 30 2024
UK Regulatory

Galapagos receives transparency notification from EcoR1 Capital

Mechelen, Belgium; 30 September 2024, 22:01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) received a transparency notification from EcoR1 Capital LLC. Pursuant to Belgian...

September 30 2024
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
11.465.6327160493825.9227.525.868464626.75356705DE
41.987.7952755905525.427.524.98052725.89893511DE
120.722.7006751687926.6628.6823.668848325.87888469DE
263.615.138772077423.7828.68229424925.51563568DE
52-10.24-27.219564061737.6239228904427.54972284DE
156-22.12-44.686868686949.566.282215848142.57534305DE
260-160.12-85.3973333333187.5252.92228193989.54714428DE

GLPG - Frequently Asked Questions (FAQ)

What is the current Galapagos share price?
The current share price of Galapagos is 27.38 €
How many Galapagos shares are in issue?
Galapagos has 65,897,000 shares in issue
What is the market cap of Galapagos?
The market capitalisation of Galapagos is EUR 1.81B
What is the 1 year trading range for Galapagos share price?
Galapagos has traded in the range of 22.00 € to 39.00 € during the past year
What is the PE ratio of Galapagos?
The price to earnings ratio of Galapagos is 8.52
What is the cash to sales ratio of Galapagos?
The cash to sales ratio of Galapagos is 2.14
What is the reporting currency for Galapagos?
Galapagos reports financial results in EUR
What is the latest annual turnover for Galapagos?
The latest annual turnover of Galapagos is EUR 843.8M
What is the latest annual profit for Galapagos?
The latest annual profit of Galapagos is EUR 211.7M
What is the registered address of Galapagos?
The registered address for Galapagos is GENERAAL DE WITTELAAN L11, MECHELEN, ANTWERP, A3 2800
What is the Galapagos website address?
The website address for Galapagos is www.glpg.com
Which industry sector does Galapagos operate in?
Galapagos operates in the COML PHYSICAL, BIOLOGCL RESH sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MLFXOFinaxo
0.895 €
(43.20%)
500
MLWEYWeya
0.0175 €
(34.62%)
5.1k
POXELPoxel
0.191 €
(33.57%)
4.22M
ALBIOBiosynex
2.50 €
(28.73%)
50.71k
SEQUASequana medical NV
3.02 €
(23.27%)
1.05M
BNBSTonner Drones
0.0005 €
(-50.00%)
524.03k
ALAGOEPango SA
0.127 €
(-41.20%)
11.94M
EIFDSTour Eiffel DS
0.0032 €
(-38.46%)
33.94k
FINMFinanciere Marjos
0.076 €
(-36.13%)
1.4k
ALALOAcheterLouerFR
0.20 €
(-33.33%)
90.63k
ATOAtos SE
0.0024 €
(-4.00%)
1.53B
BCPBanco Comercial Portugues SA
0.4623 €
(0.74%)
43.69M
ALTDTonner Drones
0.0118 €
(-7.81%)
27.49M
NEOENNeoen SA
39.74 €
(-0.15%)
21.76M
ALVERVergnet
0.002 €
(0.00%)
16.8M

Discussion

View Full Feed
crescentmotor crescentmotor 2 minutes ago
Seems like a lot of silly effort for no impact on share price come Monday-Friday.

With AVXL's MAA being accepted and under review, a favorable/supportive peer review article about to be officially released in mass distribution, and presentations of OLE trial data at the prestigious JP
AVXL JPM
mauismart mauismart 3 minutes ago
I just bought a. 2000 Toyota echo with over 100k miles for only $1200 and she gets over 30 miles to the gallon. I saved my avxl share
AVXL
carvajal carvajal 3 minutes ago

Brian's ties to Brazil date back to 2021.

" style="font-size: 1em"#HUMBL continues to advance. Please do not mistake silence for weakness."

 
HMBL
shortridge3w shortridge3w 4 minutes ago
Regarding the 1.8 point difference of ADAS-cog13 between dosed and placebo, the worst estimate could be done by extending the dosed curve 4 months, which would result in 1 point increase. This can be verified with the open label extension data.
AVXL
Risk Risk 5 minutes ago
Yes Golf. I Agree, Just want to get out man break even if it's a possiblility???
Happy to hear you made it back on Quantum stocks.
AFFU
TURCH TURCH 5 minutes ago
Yup have Rr and krknf if u find any others let me know!


Regards
doccjc doccjc 5 minutes ago
Wonder if we'll get an update on Monday ?
First full week of trading since the India  human trials announcement 
Positive human trial results may cause the stock to run imo .
RDGL
theorysuit theorysuit 6 minutes ago
Immunomedics was $10B before Gilead bought them for Trodelvy. They paid $21B before it had FDA approval.

Wrong, IMMU already had accelerated approval in mTNBC by FDA, and had confirmatory data that was stopped early for hitting their pfs and OS endpoints to support full approval. A
NWBO
doccjc doccjc 7 minutes ago
Sure as hell feels different. Obgoing human trials , IDE about to be submitted .  We're about to find out if this works in humans as well as it does in animals. No reason it shouldn't .  Share price is about to take off imo . 
RDGL
StockItOut StockItOut 10 minutes ago
Bitcoin, for example, is not lawful money.

The Note is: money or shares or both. Standard.

You really are a nutjob.
XERI
againstallodds againstallodds 10 minutes ago
A/S tells you where JarHead is headed….
NBRI
blackhawks blackhawks 11 minutes ago
Curtain is still with us.

https://en.wikipedia.org/wiki/Jane_Curtin
getmoreshares getmoreshares 12 minutes ago
.0005 next!
KATX
StockItOut StockItOut 12 minutes ago
The Note is either/or you moron.
XERI
SSKILLZ1 SSKILLZ1 12 minutes ago
Mr. Sheep Picks

There will two Mr. Sheep this contest one with cash and one without. Hope this helps.
[pre]
38 Alias: MR. SHEEP

Symbol
1 $$
2 CCEL 4-3/4 Positions
3 ETCC
4 OPXS
5
ETCC VNDA
georgejjl georgejjl 12 minutes ago
Don't forger Ern Heaven from the Phase 2a trial.

https://www.youtube.com/watch?v=8orzf4UXNLA

Good luck and GOD bless,
AVXL
quester614 quester614 13 minutes ago
There is a reason the clause lawful money is in the Auctus loan. They were never going to sell 1 shares or OPTION. ANY DECENT LAWYER should know that a specific language is used for reasons in contracts.

LOLOLOLhttps://investorshub.advfn.com/uimage/uploads/2025/1/4/qwgpiScreenshot_20
XERI
Manspider Manspider 14 minutes ago
Foolish rabbit … tricks are for kids! :-D
ASII
jay_tee jay_tee 14 minutes ago
It's obvious you still believe in Santa if you really believe I'm a paid basher. I've never once bashed RNVA
RNVA
solong solong 15 minutes ago
Read all of the tweets from the company, they aren't going for Pink Current. Do you have any idea as to who is in charge? Read the company tweets.

They've laid out where this is heading and Pink Current is not the destination.
SYIN
imho imho 15 minutes ago
I have noticed that posts by Doc and Investor critiquing Blarcamisine, avoid comparisons to the MABs. They would be correct in stating that the MABs have nothing to do in assessing if Blarcamisine works (vs a placebo). That is the premise and the basis for their conclusions.

However,
AVXL

Your Recent History

EU
GLPG
Galapagos
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads